Get started
Author

Yuko Tanaka

Observed names: TANAKA, Yuko, Tanaka, Yuko, Y Tanaka, Y. Tanaka, YUKO TANAKA, Yuko TANAKA, タナカ, ユウコ, 田中, 裕子, 田中,祐子
Observed institutions: Tokyo Medical University, Nagoya Institute of Technology, National Cancer Centre Japan, Osaka City General Hospital, Daiichi-Sankyo (Japan), Japan Tobacco (Japan), Kumamoto University Hospital, Boehringer Ingelheim (Japan), Tottori University Hospital, Tottori University, University of Yamanashi
ORCID: 0000-0002-0804-5807
Observed ORCID: 0000-0002-0804-5807
OpenAlex ID: A5101769464
Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study
2015 · Rimei Nishimura, Yuko Tanaka, et al. · Cardiovascular Diabetology · 107
PDF
Matrix Metalloproteinases in Human Diabetic and Nondiabetic Vitreous
2001 · MING JIN, KENJI KASHIWAGI, et al. · Retina · 100
First Streptococcus agalactiae Isolates Highly Resistant to Quinolones, with Point Mutations in gyrA and parC
2003 · Yoshiaki Kawamura, Hiromitsu Fujiwara, et al. · Antimicrobial Agents and Chemotherapy · 87
Designing scaffolds of peptides for phage display libraries
2005 · Fumiaki Uchiyama, Yuko Tanaka, et al. · Journal of Bioscience and Bioengineering · 64
Long‐term treatment with empagliflozin as add‐on to oral antidiabetes therapy in J apanese patients with type 2 diabetes mellitus
2015 · E. Araki, Y. Tanizawa, et al. · Diabetes Obesity and Metabolism · 62
The indirect pathogenicity of Stenotrophomonas maltophilia
2003 · Daisuke Kataoka, Hiromitsu Fujiwara, et al. · International Journal of Antimicrobial Agents · 50
Involvement of poly(ADP-ribose) metabolism in induction of differentiation of HL-60 promyelocytic leukemia cells
1982 · Mieko Kanai, Masanao Miwa, et al. · Biochemical and Biophysical Research Communications · 47
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, and Safety of Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, in Japanese Patients With Type 2 Diabetes Mellitus
2014 · Akiko Sarashina, Kohjiro Ueki, et al. · Clinical Therapeutics · 31
Effect of Empagliflozin on Free Fatty Acids and Ketone Bodies in Japanese Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
2019 · Rimei Nishimura, Yuko Tanaka, et al. · Advances in Therapy · 28
Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells
2014 · Seiichi Okabe, Tetsuzo Tauchi, et al. · Journal of Hematology & Oncology · 25
PDF
Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
1993 · M Yoshida, Y Tanaka, et al. · PubMed · 24
Linagliptin as add‐on to empagliflozin in a fixed‐dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two‐part, randomized, placebo‐controlled trial
2018 · Kohei Kaku, Masakazu Haneda, et al. · Diabetes Obesity and Metabolism · 15
PDF
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies
2017 · Masakatsu Nishikawa, Takaaki Isshiki, et al. · Cardiovascular Intervention and Therapeutics · 14
PDF
Androst-5-Ene-7,17-dione: A novel class of suicide substrate of aromatase
1992 · Mitsuteru Numazawa, Ayako Mutsumi, et al. · Biochemical and Biophysical Research Communications · 13
Phase 1 studies of the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 690517 (vicadrostat), a novel aldosterone synthase inhibitor, in healthy male volunteers
2025 · Friedrich Schulze, Jennifer Schaible, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 12
PDF
Health risk management behaviors and related factors among Japanese university students participating in short-term study abroad programs
2019 · Michiyo Yamakawa, Yuko Tanaka, et al. · Journal of Infection and Chemotherapy · 11
Lipids and acid phosphatase in cultured lymphocytes of peripheral blood. A histochemical and electron microscopic study.
1966 · Y Tanaka, T J Liddy · PubMed · 11
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cells
2018 · Seiichi Okabe, Tetsuzo Tauchi, et al. · Oncotarget · 9
PDF
Medication-taking behavior in hypertensive patients with a single-tablet, fixed-dose combination in Japan
2015 · Ikuo Saito, Toshio Kushiro, et al. · Clinical and Experimental Hypertension · 7
Tyrosine Kinase Inhibitors Do Not Promote a Decrease in SARS-CoV-2 Anti-Spike IgG after BNT162b2 Vaccination in Chronic Myeloid Leukemia: A Prospective Observational Study
2022 · Seiichiro Katagiri, Daigo Akahane, et al. · Vaccines · 5
PDF
Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial
2019 · Eiichi Araki, Yuriko Unno, et al. · Advances in Therapy · 4
PDF
Serotonergic receptor blocking potency of SGB-1534, a new antihypertensive agent, as assessed with radioligand binding assay method
1987 · Takafumi Nagatomo, Rei Hokibara, et al. · The Japanese Journal of Pharmacology · 3
PDF
322P Ivosidenib in pretreated Japanese (JPN) patients (pts) with mutant isocitrate dehydrogenase 1 (mIDH1) nonresectable/metastatic cholangiocarcinoma (n/mCCA): Phase II study results
2025 · T. Satake, Y. Maruki, et al. · Annals of Oncology · 2
PDF
Brain Activity Changes in a Resort Tour
2002 · Yoshifumi Tanaka, Kikunori Shinohara, et al. · Journal of PHYSIOLOGICAL ANTHROPOLOGY and Applied Human Science · 2
Interleukin 1 Beta As a Promising Therapeutic Target in ABL Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia Cells
2018 · Seiichi Okabe, Tetsuzo Tauchi, et al. · Blood · 1
Works count: 44
Citation count: 736
H-index: 13
I10-index: 17
Year
Topic
Type